4.2 Article

Antidepressant Tapering Is Not Routine But Could Be

期刊

出版社

AMER BOARD FAMILY MEDICINE
DOI: 10.3122/jabfm.2022.220239R1

关键词

Antidepressants; Anxiety Disorders; Bipolar Disorder; Depression; Drug Tapering; Mental Health; Primary Health Care; Psychiatry

向作者/读者索取更多资源

When discontinuing antidepressants, it is important to carefully taper the dose in order to minimize withdrawal symptoms. However, it is difficult to determine which patients will struggle without a taper. A one-size-fits-all taper approach is recommended.
Introduction: When antidepressants are discontinued, severe withdrawal symptoms are possible. Some patients have few or no problems stopping, whereas others struggle. That struggle can be minimized or prevented with careful dose tapering. How often is that done? Methods: Using 7 years of medical records, we determined the percentage of patients who received a prescription for the lowest available dose of their antidepressant before it was discontinued, as an indicator of a deliberate taper. Results: Over that period, 8.9% of patients had evidence of tapering. The percentage increased from 4.9% in 2014 to a plateau around 10% in the past 4 years. Discussion: While reports of severe withdrawal are increasingly recognized and must be addressed, our data suggest that many patients can discontinue their antidepressants without a taper through the lowest dose. However, it is difficult to identify which patients will struggle without a careful taper. A one-size-fits-all taper approach is recommended, balancing the need for withdrawal prevention with the need to avoid unnecessary complexity for the majority of patients. The first decrement is key for all patients: it must go well. Thereafter many patients may accelerate but all should receive a prescription for the lowest available dose of their antidepressant.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据